John DiBella
Lancaster, California, United States
3K followers
500+ connections
About
Simulations Plus (NASDAQ: SLP) is the premier developer of modeling & simulation software…
Activity
-
Thank you to everyone who joined us at #ASCPT 2025! We enjoyed connecting with you at our Learning Lab, “Recipe for Success: How Integrated MIDD &…
Thank you to everyone who joined us at #ASCPT 2025! We enjoyed connecting with you at our Learning Lab, “Recipe for Success: How Integrated MIDD &…
Liked by John DiBella
-
Last week, Francisco Huizar, Ph.D. and I represented Simulations Plus, Inc. at the LUPUS 2025 conference, where Francisco expertly presented over a…
Last week, Francisco Huizar, Ph.D. and I represented Simulations Plus, Inc. at the LUPUS 2025 conference, where Francisco expertly presented over a…
Liked by John DiBella
-
There's still time to register for tomorrow's webinar! ADMET Predictor 13 is almost here—and in this webinar, you’ll see how it gives your…
There's still time to register for tomorrow's webinar! ADMET Predictor 13 is almost here—and in this webinar, you’ll see how it gives your…
Liked by John DiBella
Experience
Education
-
Case Western Reserve University
-
Thesis: A computational model of skeletal muscle metabolism linking cellular adaptations induced by altered loading states to metabolic responses during exercise
-
-
Honors: cum laude
More activity by John
-
ADMET Predictor 13 is almost here—and in this webinar, you’ll see how it gives your organization the First-to-Invent Advantage! Dr. David Miller…
ADMET Predictor 13 is almost here—and in this webinar, you’ll see how it gives your organization the First-to-Invent Advantage! Dr. David Miller…
Liked by John DiBella
-
The global obesity drug market is projected to grow to $37.94 billion by 2032, driven largely by the drugs currently in development. The pace of…
The global obesity drug market is projected to grow to $37.94 billion by 2032, driven largely by the drugs currently in development. The pace of…
Liked by John DiBella
-
Transitioning with Purpose — Grateful for the Journey, Excited for What’s Ahead After 24+ years leading clinical pharmacology, with deep expertise…
Transitioning with Purpose — Grateful for the Journey, Excited for What’s Ahead After 24+ years leading clinical pharmacology, with deep expertise…
Liked by John DiBella
-
Last week, I had the privilege of attending the 12th International Conference on Composite Testing and Model Identification (CompTest 2025) in Riga…
Last week, I had the privilege of attending the 12th International Conference on Composite Testing and Model Identification (CompTest 2025) in Riga…
Liked by John DiBella
-
" Accelerate Your Drug Discovery with ADMET Predictor 13: AI/ML, HT-PBPK & Automation in Action ! " In drug discovery, ADMET and PK/PD…
" Accelerate Your Drug Discovery with ADMET Predictor 13: AI/ML, HT-PBPK & Automation in Action ! " In drug discovery, ADMET and PK/PD…
Liked by John DiBella
-
There is growing enthusiasm for AI’s potential to predict drug-induced liver injury (DILI)—but while AI-based models bring value in recognizing…
There is growing enthusiasm for AI’s potential to predict drug-induced liver injury (DILI)—but while AI-based models bring value in recognizing…
Liked by John DiBella
-
Roche PMDA Summer School 2025 is open for application. We invite PhD students and master students with outstanding qualifications to join us for a…
Roche PMDA Summer School 2025 is open for application. We invite PhD students and master students with outstanding qualifications to join us for a…
Liked by John DiBella
-
Hoje, 20 de maio, comemoramos o Dia Internacional da Pesquisa Clínica! E esse ano nosso time de Desenvolvimento Clínico decidiu celebrar a data com…
Hoje, 20 de maio, comemoramos o Dia Internacional da Pesquisa Clínica! E esse ano nosso time de Desenvolvimento Clínico decidiu celebrar a data com…
Liked by John DiBella
Other similar profiles
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore MoreOthers named John DiBella in United States
-
John Dibella
Cofounder and CEO The Sanctuary Wellness Institute
-
John DiBella
Director of Operations at Hobbs
-
John DiBella
-
John DiBella
Product Engineer
30 others named John DiBella in United States are on LinkedIn
See others named John DiBella